Interview with Chris Molloy (IDBS) on software solutions for pharma R&D

Written by Thomas Payne, Future Science Group

Chris Molloy (IDBS) spoke to Bioanalysis Zone in September 2011. Could you tell Bioanalysis Zone a little about your career to date and how you ended up in your current role? My career started in cell biology/biochemistry with GlaxoSmithKline in 1990 at the very beginning of the drive to industrialize R&D. Through 14 years with the company, I moved across many therapeutic and scientific disciplines from cancer and respiratory disease to Alzheimer’s and a range of enzyme-based therapeutic targets, working internally and in collaboration with biotech. As the company expanded, I became increasingly responsible for preclinical business improvement projects, coordinating IT...

To view this content, please register now for access

It's completely free